Page last updated: 2024-10-21

3-methoxytyramine and Skin Neoplasms

3-methoxytyramine has been researched along with Skin Neoplasms in 1 studies

3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.

Skin Neoplasms: Tumors or cancer of the SKIN.

Research Excerpts

ExcerptRelevanceReference
"Neuroblastomas are malignant tumors derived embryonically from the neural crest."1.29Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma. ( Bekri, S; Candito, M; Chambon, P; Deville, A; Soler, C; Thyss, A, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Candito, M1
Soler, C1
Deville, A1
Bekri, S1
Chambon, P1
Thyss, A1

Other Studies

1 other study available for 3-methoxytyramine and Skin Neoplasms

ArticleYear
Urinary excretion of methylated catecholamine metabolites in a child with neuroblastoma maturing into ganglioneuroma.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:1

    Topics: Adrenal Gland Neoplasms; Catecholamines; Dopamine; Ganglioneuroma; Homovanillic Acid; Humans; Infant

1996